Lymphoid Proliferations and Lymphoma Associated with Immune Deficiency, and Dysregulation in a Patient Treated with Cyclosporine Monotherapy for Psoriasis-Reference-Cited by-同舟云学术

Lymphoid Proliferations and Lymphoma Associated with Immune Deficiency, and Dysregulation in a Patient Treated with Cyclosporine Monotherapy for Psoriasis

Published:2024-05-01 Issue: Volume: Page:
ISSN:0971-4502
Container-title:Indian Journal of Hematology and Blood Transfusion
language:en
Short-container-title:Indian J Hematol Blood Transfus

Author:

Nakanishi Toshiyuki,Noto Satoshi,Nakamichi Yusuke,Nakai Mori,Takezako Naoki

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12288-024-01781-3.pdf

Reference5 articles.

1. Stern RS (2006) Lymphoma risk in psoriasis: results of the PUVA follow-up study. Arch Dermatol 142:1132–1135. https://doi.org/10.1001/archderm.142.9.1132

2. Alaggio R, Amador-Ortiz C, Anagnostopoulos I, Attygalle A, Araújo I, Berti E, Bhagat G, Borges A, Boyer DF, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng W, Choi JK, Chuang S, Coupland SE, Czader M, Davé SS, De Jong D, Du M, Elenitoba-Johnson KSJ, Ferry JA, Geyer JT, Gratzinger D, Guitart J, Gujral S, Harris MH, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury JD, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li X-Q, Lim MS, Liu W-P, Louissaint A, Marcogliese AN, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes‐Moreno S, Morice WG, Nardi V, Naresh KN, Natkunam Y, Ng S, Oschlies I, Ott G, Parrens M-C, Pulitzer M, Rajkumar SV, Rawstron AC, Rech KL, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell WA, Siebert R, Sohani AR, Tooze R, Traverse‐Glehen A, Vega F, Vergier B, Wechalekar AD, Wood BL, Xerri L, Xiao W (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 36:1720–1748. https://doi.org/10.1038/s41375-022-01620-2

3. Väkevä L, Reitamo S, Pukkala E, Sarna S, Ranki A (2008) Long-term follow-up of cancer risk in patients treated with short-term cyclosporine. Acta Derm Venereol 88:117–120. https://doi.org/10.2340/00015555-0360

4. Paul C, Ho V, McGeown C, Christophers E, Schmidtmann B, Guillaume J, Lamarque V, Dubertret L (2003) Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol 120:211–216. https://doi.org/10.1046/j.1523-1747.2003.12040.x

5. Warren RB, Griffiths CEM (2008) Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. Clin Dermatol 26:438–447. https://doi.org/10.1016/j.clindermatol.2007.11.006